The Living Guidelines: Percutaneous Coronary Interventions
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Associate Editor: Cafer Zorkun, M.D., Ph.D. [2] Phone:617-525-7431
Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.
Initial Conservative vs. Initial Invasive Strategies in patients with Unstable Angina/Non STEMI
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI Indications for Chronic Kidney Disease
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI for STEMI in Conjunction with Concomitant Fibrinolytic Therapy
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI After Failed Fibrinolysis
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
PCI after Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Ancillary Therapy for Patients Undergoing PCI for STEMI
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class III [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Oral Antiplatelet Therapy
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Drug Eluting and Bare Metal Stents
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Comprehensive Risk Reduction for Patients with Coronary and Other Vascular Disease After PCI
Smoking
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Blood Pressure Control
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Lipid Management
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Physical Activity
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Weight Management
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Diabetes Management
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Antiplatelet Agents/Anticoagulants: Aspirin
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Antiplatelet Agents/Anticoagulants: Clopidogrel
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Antiplatelet Agents/Anticoagulants: Warfarin
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIb [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Renin-Angiotensin-Aldosterone System Blockers: Aldosterone Blockade
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Beta Blockers
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Class IIa [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Influenza Vaccination
Class I [1]
Click here to comment on this section of the current guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines
Reference
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

